{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:38:47Z","timestamp":1774535927102,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":2022,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jpainsymman.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T00:32:00Z","timestamp":1385944320000},"page":"132-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy and Safety of a Six-Hour Continuous Overlap Method for Converting Intravenous to Transdermal Fentanyl in Cancer Pain"],"prefix":"10.1016","volume":"48","author":[{"given":"Renato V.","family":"Samala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Bloise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mellar P.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2013.09.001_bib1","series-title":"Cancer pain relief and palliative care","year":"1990"},{"key":"10.1016\/j.jpainsymman.2013.09.001_bib2","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpainsymman.2013.09.001_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/082585979601200110","article-title":"How should we use transdermal fentanyl (TF) for pain management in palliative care patients?","volume":"12","author":"Fainsinger","year":"1996","journal-title":"J\u00a0Palliat Care"},{"key":"10.1016\/j.jpainsymman.2013.09.001_bib4","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2165\/00003495-200161150-00014","article-title":"Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control","volume":"61","author":"Muijsers","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.jpainsymman.2013.09.001_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0304-3959(89)90148-6","article-title":"Transdermal fentanyl for pain control in patients with cancer","volume":"37","author":"Miser","year":"1989","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2013.09.001_bib6","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/0885-3924(92)90051-I","article-title":"Transdermal fentanyl: long-term analgesic studies","volume":"7","author":"Simmonds","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2013.09.001_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0885-3924(97)00361-8","article-title":"Long-term treatment of cancer pain with transdermal fentanyl","volume":"15","author":"Donner","year":"1998","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2013.09.001_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0885-3924(97)00082-1","article-title":"Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life","volume":"13","author":"Ahmedzai","year":"1997","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2013.09.001_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1049909109346427","article-title":"The use of transdermal fentanyl in cancer pain\u2014a compliance study of outpatients in Taiwan","volume":"27","author":"Chiou","year":"2010","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.jpainsymman.2013.09.001_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1191\/026921600671594561","article-title":"Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine","volume":"14","author":"Radbruch","year":"2000","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2013.09.001_bib11","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1200\/JCO.1998.16.4.1588","article-title":"Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine","volume":"16","author":"Payne","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2013.09.001_bib12","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1002\/1097-0142(20011215)92:12<3056::AID-CNCR10166>3.0.CO;2-H","article-title":"A\u00a0safe and effective method for converting cancer patients from intravenous to transdermal fentanyl","volume":"92","author":"Kornick","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2013.09.001_bib13","first-page":"691","article-title":"Six- versus 12-h conversion method from intravenous to transdermal fentanyl in chronic cancer pain: a randomized study","volume":"19","author":"Nomura","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2013.09.001_bib14","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1089\/jpm.2009.0051","article-title":"The role of fentanyl in cancer-related pain","volume":"12","author":"Prommer","year":"2009","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2013.09.001_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00000542-199301000-00007","article-title":"Transdermal fentanyl for cancer pain: repeated dose pharmacokinetics","volume":"78","author":"Portenoy","year":"1993","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpainsymman.2013.09.001_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/AJP.0b013e318266f6a5","article-title":"Serum\u00a0concentration of fentanyl during conversion from intravenous to transdermal administration to\u00a0patients with chronic cancer pain","volume":"29","author":"Nomura","year":"2013","journal-title":"Clin J Pain"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392413005149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392413005149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:11:48Z","timestamp":1760130708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392413005149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0885392413005149"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.09.001","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of a Six-Hour Continuous Overlap Method for Converting Intravenous to Transdermal Fentanyl in Cancer Pain","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}